oasis 1 trial oral semaglutide 50 mg obesity results Novo Nordisk's of meets primary endpoint Investigators present findings from OASIS

its about creating a sustainable wellness routine that helps you feel your best

For instance, Wegovy is for adults with obesity, which is defined as having a body mass index (BMI) of 30 kilograms (kg) or more

But convenience should never come at the cost of safety

Bottom line: Treatment should be individualised according to patient goals, comorbidities, and adherence potential

In other words, if you take this supplement and burn fewer calories than you take in, you will definitely not see any benefit because the body will never get to a condition where the burning of fat is necessary

Important Note This content is for educational purposes only and is not medical advice